Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Watchlist
Price: 29.72 CNY 0.24% Market Closed
Market Cap: 47.8B CNY
Have any thoughts about
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Write Note

Income Statement

Earnings Waterfall
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Revenue
76.6B CNY
Cost of Revenue
-63.3B CNY
Gross Profit
13.3B CNY
Operating Expenses
-8.8B CNY
Operating Income
4.5B CNY
Other Expenses
-727.4m CNY
Net Income
3.8B CNY

Income Statement
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Rotate your device to view
Income Statement
Currency: CNY
Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
17 374
N/A
17 857
+3%
18 800
+5%
18 858
+0%
19 259
+2%
19 235
0%
19 125
-1%
19 442
+2%
19 502
+0%
19 597
+0%
20 036
+2%
20 272
+1%
20 293
+0%
20 459
+1%
20 954
+2%
22 575
+8%
24 679
+9%
34 863
+41%
42 234
+21%
53 380
+26%
60 735
+14%
62 421
+3%
64 952
+4%
63 882
-2%
62 081
-3%
61 774
0%
61 674
0%
64 735
+5%
67 333
+4%
68 329
+1%
69 014
+1%
69 507
+1%
70 106
+1%
70 280
+0%
70 788
+1%
71 878
+2%
73 538
+2%
74 167
+1%
75 515
+2%
76 833
+2%
76 588
0%
Gross Profit
Cost of Revenue
(11 750)
(11 901)
(12 214)
(12 337)
(12 497)
(12 466)
(12 218)
(12 360)
(12 479)
(12 613)
(13 425)
(13 768)
(13 852)
(13 862)
(13 068)
(14 332)
(16 386)
(25 492)
(32 225)
(41 754)
(48 293)
(49 397)
(52 093)
(52 065)
(50 898)
(50 935)
(51 257)
(53 791)
(55 674)
(56 458)
(55 793)
(56 240)
(56 993)
(57 331)
(57 516)
(58 699)
(59 953)
(60 377)
(61 331)
(62 947)
(63 265)
Gross Profit
5 623
N/A
5 955
+6%
6 585
+11%
6 520
-1%
6 761
+4%
6 769
+0%
6 907
+2%
7 083
+3%
7 024
-1%
6 984
-1%
6 610
-5%
6 504
-2%
6 441
-1%
6 597
+2%
7 887
+20%
8 243
+5%
8 293
+1%
9 370
+13%
10 009
+7%
11 626
+16%
12 441
+7%
13 023
+5%
12 859
-1%
11 814
-8%
11 181
-5%
10 837
-3%
10 416
-4%
10 943
+5%
11 658
+7%
11 870
+2%
13 221
+11%
13 267
+0%
13 112
-1%
12 949
-1%
13 272
+2%
13 179
-1%
13 585
+3%
13 790
+2%
14 185
+3%
13 886
-2%
13 323
-4%
Operating Income
Operating Expenses
(4 695)
(4 990)
(5 391)
(5 269)
(5 421)
(5 380)
(5 742)
(5 912)
(5 970)
(5 997)
(5 454)
(5 268)
(4 844)
(4 841)
(5 979)
(5 806)
(5 903)
(6 594)
(6 586)
(8 404)
(8 477)
(8 991)
(8 961)
(8 116)
(8 120)
(7 387)
(7 172)
(7 189)
(7 529)
(7 951)
(9 010)
(8 841)
(8 743)
(8 481)
(8 665)
(8 555)
(8 966)
(9 065)
(9 473)
(9 000)
(8 801)
Selling, General & Administrative
(4 340)
(4 631)
(5 028)
(5 209)
(5 352)
(5 321)
(5 341)
(5 872)
(5 945)
(5 968)
(5 032)
(5 288)
(4 887)
(4 893)
(5 624)
(5 908)
(5 831)
(6 390)
(6 872)
(7 670)
(8 110)
(8 589)
(8 361)
(7 984)
(7 810)
(7 134)
(6 330)
(6 858)
(6 978)
(7 303)
(7 903)
(8 184)
(8 364)
(8 106)
(7 891)
(8 287)
(8 427)
(8 666)
(8 357)
(8 642)
(8 461)
Research & Development
0
0
(279)
0
0
0
(314)
0
0
0
(330)
0
0
0
(373)
0
(242)
(392)
(558)
(756)
(619)
(656)
(543)
(539)
(569)
(516)
(577)
(664)
(729)
(814)
(837)
(927)
(930)
(934)
(778)
(760)
(779)
(735)
(738)
(789)
(773)
Depreciation & Amortization
0
0
(73)
0
0
0
(76)
0
0
0
(83)
0
0
0
(86)
0
0
0
(213)
0
0
0
(444)
0
0
0
(499)
0
0
0
(529)
0
0
0
(587)
0
0
0
(641)
0
0
Other Operating Expenses
(355)
(359)
(12)
(59)
(67)
(57)
(12)
(39)
(26)
(29)
(8)
19
44
53
103
102
170
189
1 058
23
252
253
387
406
258
264
233
333
177
168
259
270
551
560
591
492
240
335
263
430
432
Operating Income
930
N/A
966
+4%
1 195
+24%
1 252
+5%
1 342
+7%
1 390
+4%
1 164
-16%
1 171
+1%
1 053
-10%
988
-6%
1 157
+17%
1 237
+7%
1 599
+29%
1 757
+10%
1 907
+9%
2 438
+28%
2 390
-2%
2 777
+16%
3 423
+23%
3 223
-6%
3 965
+23%
4 032
+2%
3 898
-3%
3 699
-5%
3 062
-17%
3 452
+13%
3 245
-6%
3 755
+16%
4 129
+10%
3 920
-5%
4 211
+7%
4 426
+5%
4 369
-1%
4 468
+2%
4 607
+3%
4 625
+0%
4 619
0%
4 724
+2%
4 712
0%
4 886
+4%
4 521
-7%
Pre-Tax Income
Interest Income Expense
215
246
172
155
137
95
246
281
288
331
310
318
363
374
556
584
1 689
1 742
531
1 257
66
(36)
156
101
71
84
429
436
529
560
529
585
502
517
450
539
656
644
389
322
280
Non-Reccuring Items
0
0
(4)
0
0
0
0
0
0
0
0
0
0
0
(4)
0
0
(2)
(119)
0
0
0
(1)
1
4
6
(4)
3
0
(0)
43
1
1
(0)
12
1
1
1
21
12
11
Gain/Loss on Disposition of Assets
(4)
(3)
(9)
0
0
(8)
(1)
0
0
0
15
0
15
15
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
118
114
113
108
95
95
219
225
383
451
463
466
310
260
34
24
24
156
184
170
189
93
76
73
43
10
70
66
5
(12)
(60)
(66)
(7)
(10)
(27)
(30)
(32)
(31)
(12)
(13)
(5)
Pre-Tax Income
1 259
N/A
1 323
+5%
1 467
+11%
1 515
+3%
1 574
+4%
1 570
0%
1 628
+4%
1 676
+3%
1 724
+3%
1 768
+3%
1 945
+10%
2 021
+4%
2 287
+13%
2 406
+5%
2 493
+4%
3 046
+22%
4 103
+35%
4 674
+14%
4 019
-14%
4 650
+16%
4 220
-9%
4 089
-3%
4 129
+1%
3 875
-6%
3 181
-18%
3 553
+12%
3 739
+5%
4 260
+14%
4 664
+9%
4 468
-4%
4 723
+6%
4 945
+5%
4 866
-2%
4 975
+2%
5 043
+1%
5 134
+2%
5 244
+2%
5 339
+2%
5 110
-4%
5 208
+2%
4 807
-8%
Net Income
Tax Provision
(278)
(312)
(257)
(263)
(268)
(248)
(283)
(279)
(308)
(310)
(386)
(382)
(399)
(414)
(374)
(505)
(517)
(576)
(485)
(578)
(668)
(685)
(687)
(640)
(533)
(659)
(647)
(724)
(808)
(701)
(754)
(789)
(798)
(830)
(790)
(804)
(818)
(841)
(851)
(886)
(802)
Income from Continuing Operations
982
1 011
1 211
1 252
1 305
1 320
1 345
1 396
1 416
1 459
1 559
1 637
1 886
1 990
2 119
2 542
3 587
4 099
3 534
4 072
3 552
3 404
3 441
3 235
2 649
2 896
3 092
3 538
3 856
3 767
3 969
4 156
4 068
4 145
4 253
4 331
4 426
4 497
4 259
4 322
4 006
Income to Minority Interest
(24)
(11)
(18)
(13)
(12)
(25)
(45)
(50)
(58)
(62)
(51)
(56)
(53)
(54)
(57)
(60)
(65)
(84)
(93)
(130)
(183)
(243)
(252)
(269)
(243)
(207)
(176)
(179)
(203)
(200)
(249)
(258)
(261)
(262)
(287)
(261)
(238)
(214)
(204)
(217)
(212)
Net Income (Common)
958
N/A
1 000
+4%
1 192
+19%
1 239
+4%
1 294
+4%
1 296
+0%
1 300
+0%
1 345
+3%
1 356
+1%
1 396
+3%
1 508
+8%
1 584
+5%
1 835
+16%
1 938
+6%
2 062
+6%
2 482
+20%
3 523
+42%
4 015
+14%
3 441
-14%
3 943
+15%
3 370
-15%
3 162
-6%
3 189
+1%
2 966
-7%
2 405
-19%
2 688
+12%
2 915
+8%
3 358
+15%
3 653
+9%
3 567
-2%
3 720
+4%
3 898
+5%
3 807
-2%
3 883
+2%
3 967
+2%
4 069
+3%
4 188
+3%
4 283
+2%
4 056
-5%
4 105
+1%
3 794
-8%
EPS (Diluted)
0.74
N/A
0.77
+4%
0.92
+19%
0.96
+4%
0.96
N/A
0.99
+3%
1.01
+2%
1.04
+3%
1.06
+2%
1.05
-1%
1.08
+3%
0.97
-10%
1.12
+15%
1.18
+5%
1.27
+8%
1.52
+20%
2.16
+42%
2.46
+14%
2.12
-14%
2.42
+14%
2.07
-14%
1.95
-6%
1.96
+1%
1.83
-7%
1.46
-20%
1.66
+14%
1.79
+8%
2.07
+16%
2.25
+9%
2.2
-2%
2.29
+4%
2.4
+5%
2.34
-3%
2.39
+2%
2.44
+2%
2.5
+2%
2.58
+3%
2.63
+2%
2.49
-5%
2.52
+1%
2.33
-8%

See Also

Discover More